Abstract
Iron is a common but crucial element in the body. The average adult has 4–5 g of iron, absorbing about 1 mg daily and losing a similar amount. Iron is absorbed from the gastrointestinal tract and attached to transferrin. It is then distributed to the peripheral tissues. About two-thirds of the iron is involved in red cell production, either in the bone marrow or in circulating erythrocytes. The rest is incorporated into myoglobin, bound in hepatocytes or attached to the two iron storage proteins ferritin and hemosiderin. The latter two proteins are stored in the liver, spleen and bone marrow, where they offer iron stores that can be readily mobilized. Ferritin consists of ferric salts and apoferritin; it is water soluble. Hemosiderin is insoluble, dark brown and usually found in macrophages; it consists of altered ferritin complexes. Hemosiderin is seen in the skin following leakage of blood into the dermis, because the dermal scavengers only slowly and inefficiently remove iron stores.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Bibliography
Iron Metabolism and Iron Deficiency
Blankship MI (1971) Dysplastic hairs in iron deficiency anemia. Cutis 7:467
Hard S (1963) Non-anemic iron deficiency as an aetiological factor in diffuse loss of hair of the scalp in woman. Acta Dermato Venereol (Stockh) 43:652 – 659
Sato S (1991) Iron deficiency: structural and microchemical changes in hair, nails and skin. Semin Dermatol 10: 313–319
Weijmer M, Neering H, Welten C (1990) Preliminary report: furuncolosis and hypoferaemia. Lancet 336:464–466
Hemochromatosis
Bothwell Th, Charlton RW, Motulsky AG (1995) Hemochromatosis. In: Scriver CR, Beaudet AL, Sly WS et al. (eds) The metabolic and molecular bases of inherited disease, 7th end, McGraw-Hill, New York, pp 2237 – 2270
Cartwright GE, Edwards CQ, Kravitz K et al. (1979) Hereditary hemochromatosis. Phenotypic expression of the disease. N Engl J Med 301:175 – 179
Chevrant-Breton J, Simon M, Bourel M et al. (1977) Cutaneous manifestations of idiopathic hemochromatosis: study of 100 cases. Arch Dermatol 113:161 – 165
Hanot VC, Chauffard AM (1882) Cirrhose hypertrophique pigmentaire dans le diabète sucré. Rev Méd 2:385–403
Mildner MS, Cook JD, Straay S et al. (1980) Idiopathic hemochromatosis, an interim report. Medicine (Baltimore) 59:34–49
Nichols GM, Bacon BR (1989) Hereditary hemochromatosis: pathogenesis and clinical features of a common disease. Am J Gastroenterol 84:851 – 862
O’Reilly FM, Carby C, Fogarty J et al. (1997) Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda. Arch Dermatol 133:1098 – 1101
Roberts AG, Whatley SD, Morgan RR et al. (1997) Increased frequency of the haemo-chromatosis Cys282Tyr mutation in sporadic porphyria cutenea tarda. Lancet 349:1025 – 1025
Santos M, Clevers HC, Marx JJM (1997) Mutation of hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda. N Engl J Med 336:1326 – 1327
Troisier CE (1871) Diabète sucré. Bull Soc Anat 16:231
Sulfur
Alapetite C, Benoit A, Moustacchi E et al. (1997) The comet assay as a repair test for prenatal diagnosis of xeroderma pigmentosum and trichothiodystrophy. J Invest Dermatol 108:154–159
Bracun R, Hemmer W, Wolf-Abdolvahab S et al. (1997) Diagnosis of trichothiodystrophy in 2 siblings. Dermatology 194:74 – 76
Chen E, Cleaver JE, Weber CA et al. (1994) Trichothyo-dystrophy: Clinical spectrum, central nervous system imaging, and biochemical characterization of two siblings. J Invest Dermatol 103:154S — 158S
Hersh JH, Klein LR, Joyce MR et al. (1993) Trichothiodystrophy and associated anomalies: a variant of SIBIDS or new symptom complex? Pediatr Dermatol 10:117–122
Itkin PH, Pittelkow MR (1990) Trichothiodystrophy: review of sulfur-deficient brittle hair syndromes and association with the ectodermal dysplasia. J Am Acad Dermatol 22:705–717
McCuaig C, Marcoux D, Rasmussen JE et al. (1993) Trichothiodystrophy associated with photosensitivity, gonadal failure, and strikking osteosclerosis. J Am Acad Dermatol 28:820 – 826
Roe DA (1969) Sulphur metabolism in relation to cutaneous disease. Br J Dermatol 81 [Suppl]: 49 – 69
Tolmie JL, Berker de D, Dawber R et al. (1994) Syndromes associated with trichothio-dystrophy. Clin Dysmorphol 3:1–14
Zinc
Brandt T (1936) Dermatitis in children with disturbance of the general condition and the adsorption of food elements. Acta Derm Venereol (Stockh) 17:513–546
Cochran RJ, Tucker SB, Flannigan SA (1985) Typical zinc therapy in acne vulgaris. Int J Dermatol 24:188 – 190
Danbolt N, Closs K (1942) Acrodermatitis enteropathica. Acta Derm Venereol (Stockh) 23:127 – 169
Delaporte E, Catteau B, Piette E (1997) Necrolytic migration erythema-like eruption in zinc deficiency associated with alcoholic liver disease. Br J Dermatol 137:1011 – 1031
Fraker PJ, Jardieu P, Cook J (1987) Zinc deficiency and immune function. Arch Dermatol 123:1699 – 1701
Krasovec M, Frenk E (1996) Acrodermatitis enteropathica secondary to Crohn’s disease. Deramtology 193:361–363
Kumar SP, Anday EK (1984) Edema, hypoproteinemia, and zinc deficiency in low-birth-weight infants. Pediatrics 73:327–329
Kuramoto Y, Igarashi Y, Tagami H (1991) Acquired zinc deficiency in breast-fed infants. Semin Dermatol 10: 309–312
Moynahan EJ, Barnes PM (1972) Zinc deficiency and a synthetic diet for lactose intolerance. Lancet 1:676
Prasad AS (1995) Zinc: an overview. Nutritition 11 [Suppl]: 93–99
Sawai T, Sugiura H, Danno K et al. (1996) Acquired acrodermatitis enteropathica during chemotherapy for acute lymphocytic leukemia in a child with Down syndrome. Br J Dermatol 135:652 – 668
Sinclair SA, Reynolds NJ (1997) Necrolytic migratory erythema and zinc deficiency. Br J Dermatol 136:783 – 785
Strobel CT, Byrne WJ, Abramovits W et al. (1978) A zinc deficiency dermatitis in patients on total parenteral nutrition. Int J Dermatol 17:575–581
Copper Menkes Syndrome
Danks DM (1995) Disorders of copper metabolism. In: Scriver CR, Beaudet AL, Sly WS et al. (eds) The metabolic and molecular bases of inherited disease, 7th end, McGraw-Hill, New York, pp 2211 – 2236
Gerdes AM, Tonnesen T, Pergament E et al. (1988) Variability in clinical expression of Menkes’ syndrome. Eur J Pediatr 148:132–135
Harris ED (1993) Menkes’ disease: perspective and update on a fatal copper disorder. Nutr Rev 51:235 – 238
Harris ED, Reddy MC, Quian Y et al. (1999) Multiple forms of the Menkes’ Cu-ATPase. Adv Exp Med Biol 448:39 – 51
Hart DB (1983) Menkes’ syndrome: an update review. J Am Acad Dermatol 9:145 – 152
Martins C, Goncalves C, Moreno A et al. (1997) Menkes’ kinky hair syndrome: ultrastructural cutaneous alterations of the elastic fibers. Pediatr Dermatol 14:347–350
Menkes JH, Alter M, Steigleder GK et al. (1962) A sexlinked recessive disorder with retardation of growth peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics 29:764 – 779
Mortimer PS, Gummer D, English J et al. (1985) Acquired progressive kinking of hair. Report of six cases and review of literature. Arch Dermatol 121:1031 – 1033
Nadal D, Baerlocher K (1988) Menkes’ disease: long-term treatment with copper and D-penicillamine. Eur J Pediatr 147:621–625
Wilson Disease
Arima M, Takeshita K, Yoshino K et al. (1977) Prognosis of Wilson’s disease in childhood. Eur J Pediatr 126:147–154
Bacon BR, Schilsky ML (1999) New knowledge of genetic pathogenesis of hemochromatosis and Wilson’s disease. Adv Intern Med 44:91 – 116
Dobyns WB, Goldstein NP, Gordon H (1979) Clinical spectrum of Wilson’s disease. Hepatolenticular degeneration. Mayo Clin Proc 54:35 – 44
Ferlan-Marolt V, Stepec S (1999) Fulminant Wilsonian hepatitis unmasked by disease progression: report of a case and review of the literature. Dig Dis Sci 44:1054–1058
Hoogenraad TU, van der Hamer CJA, Hattum JV (1984) Effective treatment of Wilson’s disease with oral zinc sulphate: two case reports. Br Med J 289:273 – 276
Kemppainen R, Palatsi R, Kallioninen M et al. A (1998) A homozygous nonsense mutation and a combination of two mutations of the Wilson’s disease gene in patients with different lysyl oxidase activities in cultured fibroblasts. J Invest Dermatol 108:35 – 39
Miyagawa S, Yoshioka A, Hatoko M et al. (1987) Systemic sclerosis-like lesions during long-term penicillamine therapy for Wilson’s disease. Br J Dermatol 116:95 – 100
Rodeck B (1999) Treatment of copper associated liver disease in childhood. Eur J Med Res 28:253 – 256
Schaefer M, Gitlin JD (1999) Genetic disorders of membrane transport. IV. Wilson’s disease and Menkes’ disease. Am J Physiol 276:311 – 314
Strickland GT, Leu ML (1975) Wilson’s disease. Clinical and laboratory manifestations in 40 patients. Medicine (Baltimore) 54:113–137
Sturniolo GC, Mesteriner C, Irato P et al. (1999) Zinc therapy increases duodenal concen-trations of metallothionein and iron in Wilson’s disease patients. Am J Gastroenterol 94:334–338
Wilson SAK (1912) Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain (London) 34:295 – 509
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Braun-Falco, O., Plewig, G., Wolff, H.H., Burgdorf, W.H.C. (2000). Disorders of Mineral Metabolism. In: Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97931-6_46
Download citation
DOI: https://doi.org/10.1007/978-3-642-97931-6_46
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97933-0
Online ISBN: 978-3-642-97931-6
eBook Packages: Springer Book Archive